Baxter International cut its annual profit forecast on Friday, citing hurricane-related disruptions at its North Carolina intravenous solutions facility, causing its shares to fall 1.3% in premarket ...

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading. The Deerfield, ...

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced today. Along ...

Leqembi is approved for Alzheimer’s patients in multiple territories, but questions remain over its cost-effectiveness.

Read about Baxter's progress in restoring its North Cove facility after Hurricane Helene-related flooding, causing widespread shortages and a $200 million loss.

First randomized placebo-controlled trial in NTM abscessusSymptom-based endpoints showed favorable improvement in frequency and severity of the most common symptomsMicrobiologic endpoints showed ...

Preclinical data demonstrated durable immune responses and tumor growth inhibition with Mural's IL-18 variants, reinforcing ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

Medtronic, a global leader in healthcare technology, unveiled results from the Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with stroke Devices in India (PRAAN) at the ...